Ingevity (NYSE:NGVT) Updates FY 2026 Earnings Guidance

Ingevity (NYSE:NGVTGet Free Report) issued an update on its FY 2026 earnings guidance on Wednesday morning. The company provided earnings per share guidance of 4.700-5.200 for the period, compared to the consensus earnings per share estimate of 4.850. The company issued revenue guidance of $1.1 billion-$1.2 billion, compared to the consensus revenue estimate of $1.2 billion.

Ingevity Stock Performance

Shares of NYSE:NGVT traded up $0.75 during midday trading on Wednesday, hitting $77.85. The company had a trading volume of 281,746 shares, compared to its average volume of 312,634. The company has a debt-to-equity ratio of 39.10, a current ratio of 1.33 and a quick ratio of 0.79. The company has a market cap of $2.75 billion, a price-to-earnings ratio of -16.74 and a beta of 1.24. Ingevity has a 12-month low of $36.47 and a 12-month high of $79.29. The company has a fifty day moving average of $71.00 and a two-hundred day moving average of $63.85.

Ingevity (NYSE:NGVTGet Free Report) last posted its quarterly earnings data on Wednesday, February 25th. The company reported $0.58 EPS for the quarter, missing the consensus estimate of $0.74 by ($0.16). The company had revenue of $255.10 million during the quarter, compared to analysts’ expectations of $257.27 million. Ingevity had a positive return on equity of 126.25% and a negative net margin of 13.51%.The company’s revenue for the quarter was down 3.2% on a year-over-year basis. During the same quarter last year, the company earned $0.95 earnings per share. Ingevity has set its FY 2026 guidance at 4.800-5.20 EPS. On average, equities research analysts expect that Ingevity will post 5.05 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on NGVT shares. Weiss Ratings restated a “sell (d-)” rating on shares of Ingevity in a research note on Tuesday, April 21st. Wells Fargo & Company increased their price target on Ingevity from $65.00 to $75.00 and gave the stock an “equal weight” rating in a research note on Friday, February 27th. BMO Capital Markets reiterated an “outperform” rating and issued a $83.00 price target on shares of Ingevity in a research note on Monday, March 2nd. Wall Street Zen lowered Ingevity from a “buy” rating to a “hold” rating in a research note on Saturday, April 4th. Finally, Jefferies Financial Group reiterated a “buy” rating and issued a $82.00 price target on shares of Ingevity in a research note on Thursday, February 26th. Two research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average price target of $80.00.

Get Our Latest Stock Report on NGVT

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. State of Tennessee Department of Treasury lifted its holdings in shares of Ingevity by 25.3% in the 4th quarter. State of Tennessee Department of Treasury now owns 20,881 shares of the company’s stock valued at $1,236,000 after acquiring an additional 4,219 shares during the last quarter. XTX Topco Ltd lifted its stake in Ingevity by 409.3% in the fourth quarter. XTX Topco Ltd now owns 21,075 shares of the company’s stock worth $1,247,000 after purchasing an additional 16,937 shares during the last quarter. Susquehanna Portfolio Strategies LLC bought a new stake in Ingevity in the fourth quarter worth about $1,112,000. Summit Securities Group LLC bought a new stake in Ingevity in the fourth quarter worth about $178,000. Finally, Evolve Private Wealth LLC bought a new stake in Ingevity in the fourth quarter worth about $319,000. Institutional investors own 91.59% of the company’s stock.

Ingevity Company Profile

(Get Free Report)

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.

Featured Articles

Receive News & Ratings for Ingevity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingevity and related companies with MarketBeat.com's FREE daily email newsletter.